Navigation Links
Dr. John Eng to receive Golden Goose Award
Date:7/30/2013

The creators of the Golden Goose Award announced today that the next award will go to Dr. John Eng, a medical researcher and practicing physician whose study of the extremely poisonous venom produced by the Gila monster led to a drug that protects millions of diabetics from such complications as blindness, kidney failure, and nerve damage.

The Golden Goose Award was created in 2012 to celebrate researchers whose seemingly odd or obscure federally funded research turned out to have a significant, positive impact on society. Dr. Eng will receive the award at the second annual Golden Goose Awards ceremony in Washington, DC this fall, along with the late Wallace Coulter, who was named a Golden Goose awardee earlier this year, and other winners to be named in the coming weeks.

Representative Jim Cooper (D-TN) first proposed the Golden Goose Award, and it was created by a coalition of organizations listed below. Like the bipartisan group of Members of Congress who support the Golden Goose Award, the founding organizations believe that federally funded basic scientific research is the cornerstone of American innovation and essential to our economic growth, health, global competitiveness, and national security. Award recipients are selected by a panel of respected scientists and university research leaders.

"Medicine from monsters and venom may sound like a science-fiction novel, but it's a real-life breakthrough," said Rep. Cooper. "Dr. Eng's research shows that we can't abandon science funding only because we don't know where it might lead. Just ask millions of diabetics whose lives have been improved by his discovery."

"Dr. Eng's research demonstrates the necessity of federally supported basic research," said Rep. Charlie Dent (R-PA), another congressional supporter of the Golden Goose Award. "In 1992, there was no way of knowing that Gila monster venom contained a compound that would one day change the lives of millions of diabetics. We owe it to future generations to lay the groundwork now for tomorrow's breakthroughs."

Dr. Eng began his career as a physician and researcher at the Veterans Administration (VA) Medical Center in the Bronx, New York, working under Nobel Prize recipient Dr. Rosalyn S. Yalow. He treated many diabetic patients, and knew that maintaining normal glucose levels in diabetics is key to reducing their chances of suffering such complications as blindness, nerve damage, and kidney failure.

According to the American Diabetes Association, in 2011 nearly 26 million people in the U.S. had diabetes. It is the leading cause of kidney failure, and the leading cause of new cases of blindness among adults aged 20-74.

Supported by funding from the Department of Veterans Affairs, Dr. Eng sought to build on earlier research by other scientists supported by the National Institutes of Health, who had found that the venom of some animals had an impact on the human pancreas.

Focusing on the poisonous venom of the Gila monster, a lizard indigenous to the southwestern U.S., Dr. Eng discovered in 1992 a new compound that he named Exendin-4. The compound stimulates insulin-producing cells in the pancreas to produce more insulin when glucose levels are high. The compound keeps the body's blood sugar levels at a steady, normal level while minimizing, compared to an insulin shot, the risk of levels going too low.

To gain notice for his discovery, Dr. Eng set up a booth at the American Diabetes Association annual meeting, where he caught the attention of a small biotechnology company, Amylin Pharmaceuticals.

The new drug developed by that company, exenatide, marketed as Byetta, was approved by the Food and Drug Administration in 2005, and has proved to be a long-acting treatment that helps diabetics manage their chronic condition. It has been prescribed to millions of people suffering from diabetes to help them to manage their blood sugar levels and to feel less hungry and eat less.


'/>"/>

Contact: Barry Toiv
barry.toiv@aau.edu
202-408-7500
Association of American Universities
Source:Eurekalert

Related biology news :

1. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
2. WHOI researchers, collaborators receive $1.4 million grant to study life in oceans greatest depths
3. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
4. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
5. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
6. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
7. UC Riverside plant cell biologist receives top scientific honor
8. UC Riverside receives grant for global health and development research
9. Washington University receives $8 million to lead international childhood malnutrition effort
10. SRI Sarnoffs Iris on the Move® N-Glance™ Identification System Receives Lenel Factory Certification
11. SF State biology department receives $1.5 million to support science teaching
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... prospective clinical study that demonstrates the accuracy of the FebriDx® test, a ... significant acute bacterial and viral respiratory tract infections by testing the body’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
(Date:10/11/2017)... NJ (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic ... one eye at a time. So which eye do you rinse first if a dangerous ... have Plum Duo Eye Wash with its unique dual eye piece. , “Whether ...
Breaking Biology Technology: